Randomized phase II study of sapanisertib (SAP) plus paclitaxel (PAC) versus PAC alone in patients (pts) with advanced, recurrent, or persistent endometrial cancer Meeting Abstract
| Authors: | Scambia, G.; Han, S. N.; Oza, A. M.; Colombo, N.; Oaknin, A.; Raspagliesi, F.; Wenham, R. M.; Braicu, E. I.; Jewell, A.; Makker, V.; Guerra, E. M.; Moxley, K. M.; Baurain, J. F.; Su, Z.; Neuwirth, R.; Vincent, S.; Sedarati, F.; Faller, D. V.; Krell, J. |
| Abstract Title: | Randomized phase II study of sapanisertib (SAP) plus paclitaxel (PAC) versus PAC alone in patients (pts) with advanced, recurrent, or persistent endometrial cancer |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368303002 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.6087 |
| Notes: | Meeting Abstract: 6087 -- Source: Wos |
